Using genetic barcoding to track individual human blood-forming cells in mice, USC researchers reveal how chemotherapy and radiation influence the regeneration of blood and immune cells, with implications for preclinical research and bone marrow transplantation strategies for patients with blood cancer and other disorders.
Researchers at the Keck School of Medicine of USC have investigated how chemotherapy and radiation before bone marrow transplantation influence the recovery of human blood and immune cells.
Using genetic barcoding, the team tracked individual human blood-forming stem cells (HSCs) and multipotent progenitor cells (MPPs) after transplanting them into mice. Both populations produced different blood and immune cell types over an extended period, suggesting human MPPs may have greater long-term regenerative capacity than earlier mouse studies indicated. However, HSCs generally produced more cells and a broader range of cell types.The researchers compared radiation, chemotherapy using busulfan, and no conditioning treatment. These approaches affected the speed, quantity and types of cells produced, without significantly changing donor cell engraftment in bone marrow. HSCs maintained more consistent production, while MPPs were more sensitive to conditioning.When transferred into a second group of mice, both populations continued producing cells, although at substantially lower levels. Production also occurred outside the bone marrow, including in enlarged spleens, highlighting limitations of the mouse model.The findings could inform more personalised transplant preparation, but further research is needed to establish their relevance to patients.
Credit: Keck School of Medicine of USC
